Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2019

01-05-2019

The kallikrein-like activity of Heloderma venom is inhibited by carbon monoxide

Authors: Vance G. Nielsen, Nathaniel Frank

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2019

Login to get access

Abstract

Lizards in the genus Heloderma are the most ancient venomous reptiles, with a traceable lineage nearly 100 million years old. The proteome of the venom of three of the remaining species (Heloderma suspectum, H. exasperatum, H. horridum) are very conserved, with kallikrein-like activity present to cause critical hypotension to immobilize and outright kill prey. Kallikrein-like activity would be expected to activate the contact protein pathway of coagulation, which would be detectable with thrombelastography in human plasma. Thus, it was proposed to determine if kallikrein-like activity could be detected with thrombelastography, and if this activity could be inhibited by carbon monoxide (CO) via a putative heme-based mechanism. Procoagulant activity of each venom was assessed via thrombelastography with normal plasma, and kallikrein-like activity confirmed with FX-depleted plasma. Venom was then exposed to carbon monoxide releasing molecule-2 (CORM-2) or its inactive releasing molecule to assess CO inhibition. All three venoms demonstrated kallikrein-like activity with the same potency and inhibition of activity by CO. In conclusion, the present work documented that procoagulant, kallikrein-like activity containing venoms of the oldest species of venomous reptiles was inhibited by CO, potentially via heme modulation. This is also the first identification and characterization of a kallikrein-like enzyme utilizing coagulation factor-depleted plasma to assess venom that inflicts hypotension. Future investigations will continue to define the vulnerability of venom enzymatic activities to CO.
Literature
1.
go back to reference Beaman KR, Beck DD, McGurty BM (2006) The beaded lizard (Heloderma horridum) and gila monster (Heloderma suspectum): a bibliography of the family Helodermatidae. Smithson Herpetol Inf Serv 136:1–66 Beaman KR, Beck DD, McGurty BM (2006) The beaded lizard (Heloderma horridum) and gila monster (Heloderma suspectum): a bibliography of the family Helodermatidae. Smithson Herpetol Inf Serv 136:1–66
2.
go back to reference Fry BG, Vidal N, Norman JA, Vonk FJ, Scheib H, Ramjan SF, Kuruppu S, Fung K, Hedges SB, Richardson MK, Hodgson WC, Ignjatovic V (2006) Early evolution of the venom system in lizards and snakes. Nature 439:584–588CrossRefPubMed Fry BG, Vidal N, Norman JA, Vonk FJ, Scheib H, Ramjan SF, Kuruppu S, Fung K, Hedges SB, Richardson MK, Hodgson WC, Ignjatovic V (2006) Early evolution of the venom system in lizards and snakes. Nature 439:584–588CrossRefPubMed
3.
go back to reference Douglas ME, Douglas MR, Schuett GW, Beck DD, Sullivan BK (2010) Conservation phylogenetics of helodermatid lizards using multiple molecular markers and a supertree approach. Mol Phylogenet Evol 55:153–167CrossRefPubMed Douglas ME, Douglas MR, Schuett GW, Beck DD, Sullivan BK (2010) Conservation phylogenetics of helodermatid lizards using multiple molecular markers and a supertree approach. Mol Phylogenet Evol 55:153–167CrossRefPubMed
4.
go back to reference Reiserer RS, Schuett GW, Beck DD (2013) Taxonomic reassessment and conservation status of the beaded lizard, Heloderma horridum (Squamata: Helodermatidae). Amphib Reptile Conserv 7:74–96 Reiserer RS, Schuett GW, Beck DD (2013) Taxonomic reassessment and conservation status of the beaded lizard, Heloderma horridum (Squamata: Helodermatidae). Amphib Reptile Conserv 7:74–96
5.
go back to reference Koludarov I, Jackson TN, Sunagar K, Nouwens A, Hendrikx I, Fry BG (2014) Fossilized venom: the unusually conserved venom profiles of Heloderma species (beaded lizards and gila monsters). Toxins 6:3582–3595CrossRefPubMedPubMedCentral Koludarov I, Jackson TN, Sunagar K, Nouwens A, Hendrikx I, Fry BG (2014) Fossilized venom: the unusually conserved venom profiles of Heloderma species (beaded lizards and gila monsters). Toxins 6:3582–3595CrossRefPubMedPubMedCentral
6.
go back to reference Sanggaard KW, Dyrlund TF, Thomsen LR, Nielsen TA, Brøndum L, Wang T, Thøgersen IB, Enghild JJ (2015) Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome. J Proteom 117:1–11CrossRef Sanggaard KW, Dyrlund TF, Thomsen LR, Nielsen TA, Brøndum L, Wang T, Thøgersen IB, Enghild JJ (2015) Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome. J Proteom 117:1–11CrossRef
7.
go back to reference Alagon A, Possani LD, Smart J, Schleuning WD (1986) Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med 164:1835–1845CrossRefPubMed Alagon A, Possani LD, Smart J, Schleuning WD (1986) Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med 164:1835–1845CrossRefPubMed
8.
go back to reference Sosa BP, Alagón AC, Martin BM, Possani LD (1986) Biochemical characterization of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum Wiegmann). Biochemistry 25:2927–2933CrossRefPubMed Sosa BP, Alagón AC, Martin BM, Possani LD (1986) Biochemical characterization of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum Wiegmann). Biochemistry 25:2927–2933CrossRefPubMed
9.
go back to reference Datta G, Tu AT (1997) Structure and other chemical characterizations of gila toxin, a lethal toxin from lizard venom. J Pept Res 50:443–450CrossRefPubMed Datta G, Tu AT (1997) Structure and other chemical characterizations of gila toxin, a lethal toxin from lizard venom. J Pept Res 50:443–450CrossRefPubMed
10.
go back to reference Ivanov I, Matafonov A, Sun MF, Cheng Q, Dickeson SK, Verhamme M, Emsley J, Gailani D (2017) Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood 129:1527–1537CrossRefPubMedPubMedCentral Ivanov I, Matafonov A, Sun MF, Cheng Q, Dickeson SK, Verhamme M, Emsley J, Gailani D (2017) Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood 129:1527–1537CrossRefPubMedPubMedCentral
11.
go back to reference Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, Dickeson SK, Li C, Sun D, Verhamme IM, Emsley J, Gailani D (2018) An update on factor XI structure and function. Thromb Res 161:94–105CrossRefPubMed Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, Dickeson SK, Li C, Sun D, Verhamme IM, Emsley J, Gailani D (2018) An update on factor XI structure and function. Thromb Res 161:94–105CrossRefPubMed
12.
go back to reference Nielsen VG, Cohen BM, Cohen E (2005) Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:222–231CrossRefPubMed Nielsen VG, Cohen BM, Cohen E (2005) Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:222–231CrossRefPubMed
13.
go back to reference Nielsen VG (2019) Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom. J Thromb Thrombolysis 47:73–79CrossRefPubMed Nielsen VG (2019) Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom. J Thromb Thrombolysis 47:73–79CrossRefPubMed
14.
go back to reference Nielsen VG, Cerruti MA, Valencia OM, Amos Q (2016) Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen. Biometals 29:913–919CrossRefPubMed Nielsen VG, Cerruti MA, Valencia OM, Amos Q (2016) Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen. Biometals 29:913–919CrossRefPubMed
15.
go back to reference Nielsen VG, Frank N (2019) Role of heme modulation in inhibition of Atheris, Atractaspis, Causus, Cerastes, Echis, and Macrovipera hemotoxic venom activity. Hum Exp Toxicol 38:216–226CrossRefPubMed Nielsen VG, Frank N (2019) Role of heme modulation in inhibition of Atheris, Atractaspis, Causus, Cerastes, Echis, and Macrovipera hemotoxic venom activity. Hum Exp Toxicol 38:216–226CrossRefPubMed
16.
go back to reference Nielsen VG, Frank N, Matika RW (2018) Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme. Biometals 31:51–59CrossRefPubMed Nielsen VG, Frank N, Matika RW (2018) Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme. Biometals 31:51–59CrossRefPubMed
17.
go back to reference Nielsen VG, Bazzell CM (2016) Carbon monoxide attenuates the effects of snake venoms containing metalloproteinases with fibrinogenase or thrombin-like activity on plasmatic coagulation. MedChemComm 7:1973–1979CrossRef Nielsen VG, Bazzell CM (2016) Carbon monoxide attenuates the effects of snake venoms containing metalloproteinases with fibrinogenase or thrombin-like activity on plasmatic coagulation. MedChemComm 7:1973–1979CrossRef
18.
go back to reference Nielsen VG, Bazzell CM (2017) Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”? J Thromb Thrombolysis 43:203–208CrossRefPubMed Nielsen VG, Bazzell CM (2017) Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”? J Thromb Thrombolysis 43:203–208CrossRefPubMed
19.
go back to reference Nielsen VG, Frank N (2018) Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma. Biometals 31:951–959CrossRefPubMed Nielsen VG, Frank N (2018) Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma. Biometals 31:951–959CrossRefPubMed
20.
go back to reference Nielsen VG, Frank N, Matika RW (2018) Effects of heme modulation on Ovophis and Trimeresurus venom activity in human plasma. Toxins (Basel) 10:E322CrossRef Nielsen VG, Frank N, Matika RW (2018) Effects of heme modulation on Ovophis and Trimeresurus venom activity in human plasma. Toxins (Basel) 10:E322CrossRef
21.
go back to reference Nielsen VG, Losada PA (2017) Direct inhibitory effects of carbon monoxide on six venoms containing fibrinogenolytic metalloproteinases. Basic Clin Pharmacol Toxicol 120:207–212CrossRefPubMed Nielsen VG, Losada PA (2017) Direct inhibitory effects of carbon monoxide on six venoms containing fibrinogenolytic metalloproteinases. Basic Clin Pharmacol Toxicol 120:207–212CrossRefPubMed
22.
go back to reference Suntravat M, Langlais PR, Sánchez EE, Nielsen VG (2018) CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom. Biometals 31:585–593CrossRefPubMedPubMedCentral Suntravat M, Langlais PR, Sánchez EE, Nielsen VG (2018) CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom. Biometals 31:585–593CrossRefPubMedPubMedCentral
23.
go back to reference Nielsen VG (2018) Crotalus atrox venom exposed to carbon monoxide has decreased fibrinogenolytic activity in vivo in rabbits. Basic Clin Pharmacol Toxicol 122:82–86CrossRefPubMed Nielsen VG (2018) Crotalus atrox venom exposed to carbon monoxide has decreased fibrinogenolytic activity in vivo in rabbits. Basic Clin Pharmacol Toxicol 122:82–86CrossRefPubMed
24.
go back to reference Murakami M, Taketomi Y, Sato H, Yamamoto K (2011) Secreted phospholipase A2 revisited. J Biochem 150:233–255CrossRef Murakami M, Taketomi Y, Sato H, Yamamoto K (2011) Secreted phospholipase A2 revisited. J Biochem 150:233–255CrossRef
25.
go back to reference Koludarov I, Jackson TN, Brouw BOD, Dobson J, Dashevsky D, Arbuckle K, Clemente CJ, Stockdale EJ, Cochran C, Debono J, Stephens C, Panagides N, Li B, Manchadi MR, Violette A, Fourmy R, Hendrikx I, Nouwens A, Clements J, Martelli P, Kwok HF, Fry BG (2017) Enter the dragon: the dynamic and multifunctional evolution of Anguimorpha lizard venoms. Toxins (Basel) 9:E242CrossRef Koludarov I, Jackson TN, Brouw BOD, Dobson J, Dashevsky D, Arbuckle K, Clemente CJ, Stockdale EJ, Cochran C, Debono J, Stephens C, Panagides N, Li B, Manchadi MR, Violette A, Fourmy R, Hendrikx I, Nouwens A, Clements J, Martelli P, Kwok HF, Fry BG (2017) Enter the dragon: the dynamic and multifunctional evolution of Anguimorpha lizard venoms. Toxins (Basel) 9:E242CrossRef
Metadata
Title
The kallikrein-like activity of Heloderma venom is inhibited by carbon monoxide
Authors
Vance G. Nielsen
Nathaniel Frank
Publication date
01-05-2019
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2019
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01853-6

Other articles of this Issue 4/2019

Journal of Thrombosis and Thrombolysis 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine